+ Watch PACB
on My Watchlist
Their new chemistries developed for their genome long-read sequencing machines are being recognized as being the best way now to completely sequences new genomes (better than Illumina, which has trounced them up until now). This stock could really improve this year as more people recognize this is the best way to sequence new genomes.
Long term trend of genomic sequencing in health care applications will create a new competitive landscape. Pacific Bio has a differentiated approach that will attract a segment of the (growing) market.
Technology is rule breaking and management is focused on improving throughput. Sales have been going up and industry seems to be providing some free promotion with all the papers that are being written/published.
New product, product updates, growth ahead
This stock has been much higher than this and will return to 2 bagger status
Has it finally turned the corner? It's been up pretty big lately, and I'm making a CAPS bet that it'll continue.
Both PACB and GNOM are beat up right now, and it's only a matter of time before one of them takes off. It may be smart to buy both instead of guessing which one
This is the risky one, but they will either pull the rabbit out of the hat or not. They have a machine that does gene resequencing for about a thousand dollars. A stock at the price I would be willing to invest in because I believe in the product and will put some money behind it. Just not a lot of money. All I can lose is 3.93 a share.
No place to go but up.
investigation...and i own some. i am the kiss of death!
This highly volitile stock is definately a speculative play for a while. Shares droped 30% after some bad news regarding gross margins. I believe that drop was a bit drastic.
They had a great quarterly report but got creamed due to a JPM downgrade. It's a long-term spec stock with great potential.
Mark this date down. Who buys 1.5 million shares after hours? Something is going on.............
Is gearing up for explosive growth.
i like where their technology is going
Clearly the most powerful technology with a large void to fill in the sequencing space. Granted it will have a slow start as centers have to phase out current technology over time but once momentum picks up this run will be hard to stop.
Beaten down after not living up to product performance promises made to initial investors:http://www.fool.com/investing/high-growth/2011/05/13/pacific-biosciences-has-a-pr-problem.aspx?source=itxsitmot0000001&lidx=2BUT, beaten down price does not consider the amount of revenue it is still capable of generating (plus over $30M of orders in the short term):http://www.fool.com/investing/high-growth/2011/05/23/2-must-own-tech-stocks-and-1-to-watch.aspx?source=ihpsitth0000001
This is a technology that requires a "REV UP" Period , but once this Technology establishes itself by simply showing the world that It can do ... What it says it Can Do ... and from there it should be a Moon Shot !!!
Their SMRT technology will revolutionize genomics, clinical research and drug making. Hold on because I'm sure it will be a bumpy ride to the top!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions